Efficacy of Resveratrol Supplementation against Non-Alcoholic Fatty Liver Disease: A Meta-Analysis of Placebo-Controlled Clinical Trials

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease with rising prevalence. Increasing evidence has demonstrated that resveratrol, a dietary phytochemical, is capable of attenuating NAFLD development and progression; however, results from clinical studies are inconsist...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Chongyang, Yuan, Weigang, Fang, Jianguo, Wang, Wenqing, He, Pei, Lei, Jiahui, Wang, Chunxu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999224/
https://www.ncbi.nlm.nih.gov/pubmed/27560482
http://dx.doi.org/10.1371/journal.pone.0161792

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4999224/
https://www.ncbi.nlm.nih.gov/pubmed/27560482
http://dx.doi.org/10.1371/journal.pone.0161792

Ejemplares similares